Published on
Oct 30, 2026
California Biotech Lays Off Nearly All Staff After 2 Deaths in Cell Therapy Trials
Biotech company Artiva Biotherapeutics plans to lay off roughly 94 percent of its workforce and abandon its cell therapy treatment for rheumatoid arthritis after clinical trial data showed a lack of long-term benefits and two patient deaths. Data gathered …
Source:
The Epoch Times
-
Right-wing
